Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_imr90r1_promoter_p_RM_12_39_5			3	1.0	9.98E-05	ULBP2, MICA, PCSK2	enkephalin processing [BP], islet amyloid polypeptide processing [BP], MHC class I protein complex [CC]
CG_imr90r1_promoter_p_RM_12_129_7			2	1.0	3.40E-04	MED25, GM2A	positive regulation of chromatin binding [BP], positive regulation of mediator complex assembly [BP], sphingolipid activator protein activity [MF]
CG_imr90r1_promoter_p_RM_12_111_5			2	1.0	2.03E-05	VAX2	retina development in camera-type eye [BP]
CG_imr90r1_promoter_p_RM_12_44_10			3	1.0	1.17E-04	FBXO9, ASRGL1, FBXW8	asparagine catabolic process via L-aspartate [BP], SCF ubiquitin ligase complex [CC]
CG_imr90r1_promoter_p_RM_14_15_2			1	0.5	7.82E-05	OS9	Hrd1p ubiquitin ligase complex [CC]
CG_imr90r1_promoter_p_RM_12_37_8			3	1.0	1.74E-04	THNSL2, SULT2B1, INPPL1, MLPH	steroid sulfotransferase activity [MF], cortical actin cytoskeleton [CC], threonine synthase activity [MF], 2-oxobutyrate biosynthetic process [BP], actin cortical patch [CC], serine binding [MF], sulfate assimilation [BP], threonine biosynthetic process [BP], alcohol sulfotransferase activity [MF]
CG_imr90r1_promoter_p_RM_18_5_1			1	0.5	1.21E-04	CLVS2, GCC2	late endosome to Golgi transport [BP], Golgi ribbon formation [BP], regulation of protein exit from endoplasmic reticulum [BP], recycling endosome to Golgi transport [BP], trans-Golgi network [CC]
CG_imr90r1_promoter_p_RM_14_7_3			1	0.5	2.60E-04	KLF11, OR4C6, OR2L3, OR6C4, OR4C16, OR6C75	olfactory receptor activity [MF], regulation of transcription involved in S phase of mitotic cell cycle [BP], G-protein coupled receptor activity [MF]
CG_imr90r1_promoter_p_RM_12_45_5			6	1.0	1.13E-04	BMP15, ACER2	granulosa cell development [BP], negative regulation of protein glycosylation in Golgi [BP]
CG_imr90r1_promoter_p_RM_12_41_15			4	1.0	1.45E-04	PGM2, IRF4, CYP27A1	positive regulation of interleukin-13 biosynthetic process [BP], phosphopentomutase activity [MF], cholestanetriol 26-monooxygenase activity [MF], cholesterol 26-hydroxylase activity [MF]
CG_imr90r1_promoter_p_RM_12_62_7			4	1.0	1.40E-04	GRHPR	glycerate dehydrogenase activity [MF], hydroxypyruvate reductase activity [MF], glyoxylate reductase (NADP) activity [MF]
CG_imr90r1_promoter_p_RM_18_7_1			1	0.5	4.53E-05	SIN3B	Y chromosome [CC], autosome [CC]
CG_imr90r1_promoter_p_RM_12_8_10			4	1.0	1.95E-04	EMG1	rRNA (pseudouridine) methyltransferase activity [MF]
CG_imr90r1_promoter_p_RM_12_64_6			2	0.5	1.53E-04	CHMP7	late endosome to vacuole transport [BP]
CG_imr90r1_promoter_p_RM_14_19_1			1	0.5	2.37E-05	SLC25A27, PDK3	reduction of mitochondrial calcium ion concentration [BP], hypoxia-inducible factor-1alpha signaling pathway [BP]
CG_imr90r1_promoter_p_RM_12_66_8			2	1.0	7.35E-05	TBXAS1, RYR2	thromboxane-A synthase activity [MF], positive regulation of calcium-transporting ATPase activity [BP], intrinsic apoptotic signaling pathway in response to osmotic stress [BP], left ventricular cardiac muscle tissue morphogenesis [BP], positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor signaling pathway involved in positive regulation of cardiac muscle contraction [BP], suramin binding [MF]
CG_imr90r1_promoter_p_RM_12_47_6			3	1.0	1.39E-04	PRPS2	carbohydrate binding [MF]
CG_imr90r1_promoter_p_RM_16_10_1			2	1.0	2.06E-04	CENPA	condensed chromosome inner kinetochore [CC]
CG_imr90r1_promoter_p_RM_12_60_5			5	1.0	1.37E-04	ABCG1, CA3, POU3F3	metanephric thick ascending limb development [BP], metanephric macula densa development [BP], glycoprotein transport [BP], detection of hormone stimulus [BP], response to high density lipoprotein particle stimulus [BP], nickel cation binding [MF], sterol-transporting ATPase activity [MF], glycoprotein transporter activity [MF]
CG_imr90r1_promoter_p_RM_18_8_1			2	1.0	1.30E-04	GDA	guanine catabolic process [BP], guanine deaminase activity [MF]
CG_imr90r1_promoter_p_RM_18_3_1			1	0.5	3.34E-05	MPV17L, SFR1	negative regulation of hydrogen peroxide biosynthetic process [BP], Swi5-Sfr1 complex [CC]
CG_imr90r1_promoter_p_RM_12_86_3			2	1.0	2.26E-04	PDZD3, MYO7A	negative regulation of cGMP biosynthetic process [BP], guanylate cyclase inhibitor activity [MF], myosin complex [CC], negative regulation of guanylate cyclase activity [BP], subapical complex [CC]
CG_imr90r1_promoter_p_RM_12_29_5			2	1.0	1.10E-04	ESR1, C9orf89	negative regulation of I-kappaB kinase/NF-kappaB cascade [BP], estrogen-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [MF]
CG_imr90r1_promoter_p_RM_12_123_5			1	0.5	1.55E-04	ZIC3	determination of left/right asymmetry in nervous system [BP]
CG_imr90r1_promoter_p_RM_12_6_13			4	1.0	3.14E-04	BRCC3	histone H2A K63-linked deubiquitination [BP]
CG_imr90r1_promoter_p_RM_12_143_4			3	1.0	1.30E-04	ZNF253, ZNF273, ZNF714, ZNF492, ZNF430, ZNF729	transcription, DNA-dependent [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF]
CG_imr90r1_promoter_p_RM_14_18_1			1	0.5	6.79E-05	GMPR, SNX10, XPOT	tRNA export from nucleus [BP], extrinsic to endosome membrane [CC], GMP reductase activity [MF]
CG_imr90r1_promoter_p_RM_12_122_3			1	0.5	1.51E-04	APOBEC3B, APOBEC3F	negative regulation of transposition [BP]
CG_imr90r1_promoter_p_RM_12_88_5			2	1.0	9.67E-05	ATOH1	positive regulation of auditory receptor cell differentiation [BP], auditory receptor cell fate specification [BP]
CG_imr90r1_promoter_p_RM_12_59_4			5	1.0	9.62E-05	MYOD1, WNT9B	establishment of planar polarity involved in nephron morphogenesis [BP], positive regulation of myoblast fusion [BP]
CG_imr90r1_promoter_p_RM_12_74_4			2	0.5	1.14E-04	U2SURP, ULK1	radial glia guided migration of cerebellar granule cell [BP], nucleotide binding [MF]
CG_imr90r1_promoter_p_RM_12_72_9			5	1.0	9.24E-05	MPI, FUT8, STT3A	protein N-linked glycosylation [BP], protein N-linked glycosylation via asparagine [BP]
CG_imr90r1_promoter_p_RM_16_6_1			1	0.5	1.96E-04	SOX4	ascending aorta morphogenesis [BP], positive regulation of N-terminal peptidyl-lysine acetylation [BP], neuroepithelial cell differentiation [BP], atrial septum primum morphogenesis [BP]
CG_imr90r1_promoter_p_RM_16_3_1			1	0.5	3.16E-04	HTT, SMAD4	diazepam binding [MF], metanephric mesenchyme morphogenesis [BP], neural plate formation [BP], transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [MF], activin responsive factor complex [CC], protein import into nucleus [BP], dynein intermediate chain binding [MF], mesoderm development [BP], lactate biosynthetic process from pyruvate [BP], anterior/posterior pattern specification [BP], nephrogenic mesenchyme morphogenesis [BP], SMAD protein complex [CC], quinolinate biosynthetic process [BP], regulation of protein phosphatase type 2A activity [BP]
CG_imr90r1_promoter_p_RM_14_21_2			1	0.5	1.17E-04	SC5DL	cholesterol biosynthetic process via lathosterol [BP], C-5 sterol desaturase activity [MF], lathosterol oxidase activity [MF]
CG_imr90r1_promoter_p_RM_12_58_6			3	0.5	3.47E-05	FAM103A1	recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex [BP]
CG_imr90r1_promoter_p_RM_12_14_3			3	0.5	1.29E-04	QSOX1, TWIST2	negative regulation of myeloid cell differentiation [BP], flavin-linked sulfhydryl oxidase activity [MF]
CG_imr90r1_promoter_p_RM_16_4_1			1	0.5	1.01E-05	POR, OXA1L	mitochondrial proton-transporting ATP synthase complex assembly [BP], mitochondrial ribosome binding [MF], iron-cytochrome-c reductase activity [MF], cellular organofluorine metabolic process [BP], nitric oxide catabolic process [BP], regulation of growth plate cartilage chondrocyte proliferation [BP], nitrate catabolic process [BP]
CG_imr90r1_promoter_p_RM_12_78_9			3	1.0	1.56E-04	CHRNB2, PRDM13, BMP2, IL13RA1	neurogenesis [BP], lateral geniculate nucleus development [BP], positive regulation of Wnt receptor signaling pathway by BMP signaling pathway [BP], interleukin-13 receptor complex [CC]
CG_imr90r1_promoter_p_RM_12_73_3			2	0.5	5.29E-05	ALPL	anchored to membrane [CC], cementum mineralization [BP]
CG_imr90r1_promoter_p_RM_12_42_7			6	1.0	3.99E-05	TSPO, TAOK1, NOD2, PSTPIP1	negative regulation of interleukin-18 production [BP], muramyl dipeptide binding [MF], positive regulation of dendritic cell cytokine production [BP], detection of muramyl dipeptide [BP], positive regulation of JNK cascade [BP], nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [BP], positive regulation of prostaglandin-E synthase activity [BP], positive regulation of stress-activated MAPK cascade [BP], negative regulation of tumor necrosis factor production [BP]
CG_imr90r1_promoter_p_RM_12_114_6			1	0.5	1.45E-04	LANCL2	positive regulation of abscisic acid mediated signaling pathway [BP]
CG_imr90r1_promoter_p_RM_12_54_4			1	0.5	1.58E-05	KIF3B, DNAI2	microtubule motor activity [MF], plus-end kinesin complex [CC]
CG_imr90r1_promoter_p_RM_12_144_10			2	1.0	2.18E-04	BHMT, OS9	Hrd1p ubiquitin ligase complex [CC], regulation of homocysteine metabolic process [BP], betaine-homocysteine S-methyltransferase activity [MF]
CG_imr90r1_promoter_p_RM_20_1_2			2	1.0	1.33E-04	PSMD14	proteasome regulatory particle, lid subcomplex [CC]
CG_imr90r1_promoter_p_RM_12_13_11			3	0.5	1.32E-04	GABRA6, KCTD16, MAGEE1, LRFN3	postsynaptic membrane [CC]
CG_imr90r1_promoter_p_RM_12_10_11			2	0.5	1.18E-04	MARCKS, USPL1, DISP1	SUMO-specific isopeptidase activity [MF], Cajal body organization [BP], patched ligand maturation [BP], germinal vesicle [CC]
CG_imr90r1_promoter_p_RM_12_46_5			3	1.0	3.28E-04	FGFR4, PRKCA	peptidyl-tyrosine phosphorylation [BP], positive regulation of dense core granule biogenesis [BP], fibroblast growth factor receptor signaling pathway [BP]
CG_imr90r1_promoter_p_RM_12_12_13			1	0.5	1.76E-04	GCC2	late endosome to Golgi transport [BP], recycling endosome to Golgi transport [BP]
CG_imr90r1_promoter_p_RM_12_3_4			1	0.5	1.91E-05	SLC38A3, CRTAP, DCSTAMP	asparagine transport [BP], L-asparagine transmembrane transporter activity [MF], peptidyl-proline hydroxylation to 3-hydroxy-L-proline [BP], histidine transport [BP], osteoclast fusion [BP], positive regulation of macrophage fusion [BP]
CG_imr90r1_promoter_p_RM_12_79_5			4	1.0	2.00E-04	UGT1A1, OPRM1	morphine receptor activity [MF], negative regulation of Wnt protein secretion [BP], cytochrome complex [CC], bilirubin conjugation [BP], biphenyl catabolic process [BP], beta-endorphin receptor activity [MF]
CG_imr90r1_promoter_p_RM_12_50_7			4	1.0	7.79E-05	ST6GALNAC5	alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [MF]
CG_imr90r1_promoter_p_RM_16_9_1			2	0.5	2.31E-05	SPCS1, RFX6	regulation of insulin secretion [BP], pancreatic D cell differentiation [BP], signal peptidase complex [CC], pancreatic epsilon cell differentiation [BP]
CG_imr90r1_promoter_p_RM_12_56_4			3	0.5	1.43E-04	MAT2B	methionine adenosyltransferase regulator activity [MF], extracellular polysaccharide biosynthetic process [BP], dTDP-4-dehydrorhamnose reductase activity [MF], methionine adenosyltransferase complex [CC]
CG_imr90r1_promoter_p_RM_12_23_11			3	0.5	1.62E-04	RLF, COL8A1	DNA mediated transformation [BP], collagen type VIII [CC]
CG_imr90r1_promoter_p_RM_12_112_8			1	0.5	1.41E-04	KIF19, JAK2	mineralocorticoid receptor signaling pathway [BP], histone H3-Y41 phosphorylation [BP], histone kinase activity (H3-Y41 specific) [MF], positive regulation of growth hormone receptor signaling pathway [BP], plus-end specific microtubule depolymerization [BP], activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [BP], axonemal microtubule depolymerization [BP]
CG_imr90r1_promoter_p_RM_12_52_3			1	0.5	6.29E-05	DNAAF1	motile cilium assembly [BP], regulation of cilium beat frequency [BP], outer dynein arm assembly [BP], inner dynein arm assembly [BP]
CG_imr90r1_promoter_p_RM_12_84_4			1	0.5	6.46E-05	CDH13, CDH15, ALPL, FBLIM1	cell junction assembly [BP], adiponectin binding [MF], caveola [CC], cementum mineralization [BP], metal ion binding [MF]
CG_imr90r1_promoter_p_RM_20_11_1			1	0.5	1.45E-04	ADC, CYP4B1	fluorene metabolic process [BP], agmatine biosynthetic process [BP], arginine decarboxylase activity [MF], ornithine decarboxylase activator activity [MF], fluorene oxygenase activity [MF]
CG_imr90r1_promoter_p_RM_12_75_6			2	0.5	5.06E-05	LEPROT, NT5E, ACADM, CTNNB1	medium-chain fatty acid catabolic process [BP], protein localization to cell surface [BP], regulation of protein localization to cell surface [BP], negative regulation of growth hormone receptor signaling pathway [BP], adenosine biosynthetic process [BP]
CG_imr90r1_promoter_p_RM_12_116_6			3	1.0	2.68E-05	PRKCA	positive regulation of dense core granule biogenesis [BP]
CG_imr90r1_promoter_p_RM_16_7_1			1	0.5	1.82E-04	FTSJD2	mRNA (nucleoside-2'-O-)-methyltransferase activity [MF], mRNA methylation [BP]
CG_imr90r1_promoter_p_RM_12_80_4			2	1.0	2.75E-04	PTEN, CFTR, PML	postsynaptic density assembly [BP], negative regulation of cyclin-dependent protein kinase activity involved in G1/S [BP], channel-conductance-controlling ATPase activity [MF], chloride channel inhibitor activity [MF], phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [MF], extrinsic to endoplasmic reticulum membrane [CC], inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [MF], ATP-binding and phosphorylation-dependent chloride channel activity [MF], negative regulation of synaptic vesicle clustering [BP], negative regulation of translation in response to oxidative stress [BP], negative regulation of ribosome biogenesis [BP]
CG_imr90r1_promoter_p_RM_12_119_3			2	1.0	5.07E-04	ACVR1B, TOP1, IFT43, POU3F2	positive regulation of trophoblast cell migration [BP], neurohypophysis development [BP], replication fork protection complex [CC], intraflagellar retrograde transport [BP]
CG_imr90r1_promoter_p_RM_12_1_3			2	1.0	8.57E-05	ASS1	argininosuccinate synthase activity [MF]
CG_imr90r1_promoter_p_RM_12_49_5			2	0.5	1.51E-04	STAM, ARL6, AP2B1, SEC24B, GGA1	clathrin adaptor complex [CC], negative regulation of epidermal growth factor receptor signaling pathway [BP], membrane coat [CC], intracellular protein transport [BP]
CG_imr90r1_promoter_p_RM_12_22_4			2	1.0	3.60E-04	FEM1B, GTPBP8, HPRT1	GMP catabolic process [BP], regulation of DNA damage checkpoint [BP], positive regulation of dopamine metabolic process [BP], GMP salvage [BP], guanine salvage [BP], adenine salvage [BP], hypoxanthine phosphoribosyltransferase activity [MF], guanine phosphoribosyltransferase activity [MF], barrier septum assembly [BP]
CG_imr90r1_promoter_p_RM_12_11_8			2	1.0	1.14E-04	MS4A2, NEU4	exo-alpha-(2->8)-sialidase activity [MF], exo-alpha-(2->3)-sialidase activity [MF], Fc-epsilon receptor I complex [CC], exo-alpha-sialidase activity [MF], exo-alpha-(2->6)-sialidase activity [MF]
CG_imr90r1_promoter_p_RM_12_76_10			2	0.5	6.28E-05	IL36G, GDF7, ARFGEF2, IL23A, IL4	positive regulation of tyrosine phosphorylation of Stat5 protein [BP], positive regulation of tumor necrosis factor production [BP], cytokine activity [MF], positive regulation of activated T cell proliferation [BP], positive regulation of interleukin-10 production [BP]
CG_imr90r1_promoter_p_RM_14_8_2			3	0.5	1.31E-04	ACADM, B3GNT5	beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [MF], medium-chain fatty acid catabolic process [BP], lipopolysaccharide N-acetylglucosaminyltransferase activity [MF], lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [MF]
CG_imr90r1_promoter_p_RM_12_125_9			2	1.0	7.20E-05	RNF111, SEH1L	attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation [BP], SUMO polymer binding [MF]
CG_imr90r1_promoter_p_RM_12_21_10			5	1.0	1.50E-04	STS, SGMS2	sphingolipid metabolic process [BP]
CG_imr90r1_promoter_p_RM_12_102_5			2	1.0	1.46E-04	PAPD7, ADRB1	SMC family protein binding [MF], beta1-adrenergic receptor activity [MF], positive regulation of the force of heart contraction by norepinephrine [BP], positive regulation of cell growth involved in cardiac muscle cell development [BP]
CG_imr90r1_promoter_p_RM_12_90_5			2	1.0	1.39E-05	CLYBL	citrate lyase complex [CC], citrate (pro-3S)-lyase activity [MF]
CG_imr90r1_promoter_p_RM_12_28_9			6	1.0	1.09E-04	ITPR1, SYT9	regulation of insulin secretion [BP], secretory granule membrane [CC]
CG_imr90r1_promoter_p_RM_12_82_7			4	1.0	1.54E-04	CYP1A2	oxidative deethylation [BP], toxin biosynthetic process [BP]
CG_imr90r1_promoter_p_RM_12_92_5			2	1.0	1.59E-05	OS9, MAEA	Hrd1p ubiquitin ligase complex [CC], enucleate erythrocyte development [BP]
CG_imr90r1_promoter_p_RM_12_138_5			1	0.5	1.82E-04	AK5, OXT	positive regulation of hindgut contraction [BP], oxytocin receptor binding [MF], ADP biosynthetic process [BP], neurohypophyseal hormone activity [MF], positive regulation of female receptivity [BP], dADP biosynthetic process [BP], positive regulation of norepinephrine secretion [BP]
CG_imr90r1_promoter_p_RM_16_5_1			2	1.0	1.34E-04	IL24	serine phosphorylation of STAT3 protein [BP]
CG_imr90r1_promoter_p_RM_12_127_3			4	1.0	2.19E-04	WNT16	optic cup formation involved in camera-type eye development [BP]
CG_imr90r1_promoter_p_RM_20_8_1			1	0.5	2.52E-04	NAGK, DRD5	norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [BP], dopamine neurotransmitter receptor activity, coupled via Gs [MF], N-acetylglucosamine kinase activity [MF], N-acetylmannosamine metabolic process [BP], sensitization [BP], regulation of systemic arterial blood pressure by vasopressin [BP], negative regulation of NAD(P)H oxidase activity [BP]
CG_imr90r1_promoter_p_RM_14_2_3			6	1.0	9.89E-05	SPATA13, VAV1, SWI5	guanyl-nucleotide exchange factor activity [MF], Rho guanyl-nucleotide exchange factor activity [MF], Swi5-Sfr1 complex [CC]
CG_imr90r1_promoter_p_RM_12_106_4			2	1.0	4.06E-05	NR2F2, PCYOX1	radial pattern formation [BP], chloride-transporting ATPase activity [MF], prenylcysteine oxidase activity [MF]
CG_imr90r1_promoter_p_RM_12_5_6			4	1.0	1.79E-04	GMPS	GMP synthase (glutamine-hydrolyzing) activity [MF], GMP synthase activity [MF]
CG_imr90r1_promoter_p_RM_14_10_2			1	0.5	4.43E-05	SLC25A5, PROM2	adenine transmembrane transporter activity [MF], prominosome [CC]
CG_imr90r1_promoter_p_RM_12_32_5			3	0.5	7.11E-05	HDAC1, MESP2, GATA4, DTX4	lung lobe formation [BP], activating transcription factor binding [MF], signal transduction involved in regulation of gene expression [BP], Notch signaling pathway [BP]
CG_imr90r1_promoter_p_RM_12_15_3			5	1.0	6.27E-05	CSF1, UBIAD1	mammary gland fat development [BP], menaquinone biosynthetic process [BP]
CG_imr90r1_promoter_p_RM_12_24_5			5	1.0	4.51E-05	CREB1, CLN8, IL20RB	negative regulation of type IV hypersensitivity [BP], regulation of cell size [BP], L-glutamate uptake involved in synaptic transmission [BP]
CG_imr90r1_promoter_p_RM_12_30_4			2	0.5	1.11E-04	PIPOX	L-lysine catabolic process to acetyl-CoA via L-pipecolate [BP], L-pipecolate oxidase activity [MF], sarcosine oxidase activity [MF]
CG_imr90r1_promoter_p_RM_12_133_6			2	1.0	1.38E-04	IFNAR2, MYO3A, PCK2	type I interferon receptor activity [MF], type I interferon binding [MF], plus-end directed microfilament motor activity [MF], phosphoenolpyruvate carboxykinase activity [MF], phosphoenolpyruvate carboxykinase (GTP) activity [MF]
CG_imr90r1_promoter_p_RM_12_104_5			1	0.5	1.66E-05	SIVA1	CD27 receptor binding [MF]
CG_imr90r1_promoter_p_RM_12_99_6			1	0.5	5.62E-05	INMT	thioether S-methyltransferase activity [MF], amine N-methyltransferase activity [MF]
CG_imr90r1_promoter_p_RM_12_53_3			1	0.5	1.66E-04	NUDT9	ADP catabolic process [BP]
CG_imr90r1_promoter_p_RM_14_12_2			1	0.5	2.18E-04	KIR2DL3, PCDHGA8, PCDHGA9, KIR3DL2, PCDHGA6, PCDHGA7, FCAR	homophilic cell adhesion [BP], IgA binding [MF], plasma membrane [CC], calcium ion binding [MF], integral to membrane [CC]
CG_imr90r1_promoter_p_RM_12_132_8			2	1.0	1.48E-05	AACS, CYP26A1, EDN1	response to testosterone stimulus [BP], phospholipase D-activating G-protein coupled receptor signaling pathway [BP], positive regulation of hormone secretion [BP], acetoacetate-CoA ligase activity [MF], protein kinase C deactivation [BP], endothelin B receptor binding [MF], positive regulation of odontogenesis [BP], neural crest cell development [BP], endothelin A receptor binding [MF]
CG_imr90r1_promoter_p_RM_12_140_4			1	0.5	1.42E-04	PDXK	lithium ion binding [MF], pyridoxal phosphate biosynthetic process [BP], pyridoxal 5'-phosphate salvage [BP], pyridoxal kinase activity [MF]
CG_imr90r1_promoter_p_RM_14_14_3			1	0.5	6.08E-05	SLC6A1	gamma-aminobutyric acid import [BP], positive regulation of gamma-aminobutyric acid secretion [BP], response to sucrose stimulus [BP], negative regulation of synaptic transmission, GABAergic [BP]
CG_imr90r1_promoter_p_RM_12_87_4			3	1.0	1.21E-04	NR2F2, H6PD	radial pattern formation [BP], glucose 1-dehydrogenase [NAD(P)] activity [MF]
CG_imr90r1_promoter_p_RM_20_6_1			1	0.5	6.75E-05	GCC2	late endosome to Golgi transport [BP], Golgi ribbon formation [BP], recycling endosome to Golgi transport [BP]
CG_imr90r1_promoter_p_RM_12_108_4			2	1.0	8.29E-05	IKZF1	positive regulation of neutrophil differentiation [BP]
CG_imr90r1_promoter_p_RM_12_27_10			6	1.0	2.12E-04	IGF1R	inactivation of MAPKK activity [BP]
CG_imr90r1_promoter_p_RM_12_35_8			3	1.0	8.05E-05	NADSYN1, NSDHL, MGAT2	sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [MF], alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], NAD+ synthase (glutamine-hydrolyzing) activity [MF]
CG_imr90r1_promoter_p_RM_12_51_3			4	1.0	5.89E-05	CD1E, SLC35A1, CHSY3, CEL	protein esterification [BP], CMP-N-acetylneuraminate transport [BP], CMP-N-acetylneuraminate transmembrane transporter activity [MF], intestinal lipid catabolic process [BP], Golgi membrane [CC]
CG_imr90r1_promoter_p_RM_14_16_2			2	1.0	1.14E-04	NUP205	protein import into nucleus, docking [BP]
CG_imr90r1_promoter_p_RM_14_22_2			1	0.5	1.46E-04	ULK1, HSD17B4, KLHL20, FAAH	radial glia guided migration of cerebellar granule cell [BP], fatty acid amide hydrolase activity [MF], 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [MF], 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [MF], interferon-gamma binding [MF], very long-chain fatty-acyl-CoA metabolic process [BP]
CG_imr90r1_promoter_p_RM_14_4_2			2	1.0	9.58E-05	P2RX2	detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [BP]
CG_imr90r1_promoter_p_RM_12_115_3			2	1.0	1.00E-04	BCL2L11, AQP9, ARRB2	pyrimidine nucleobase transport [BP], BIM-BCL-xl complex [CC], type 2A serotonin receptor binding [MF], alpha-1A adrenergic receptor binding [MF], BIM-BCL-2 complex [CC], pyrimidine nucleobase transmembrane transporter activity [MF], alpha-1B adrenergic receptor binding [MF], follicle-stimulating hormone receptor binding [MF], D1 dopamine receptor binding [MF]
CG_imr90r1_promoter_p_RM_14_20_2			1	0.5	1.57E-04	TNFAIP3	negative regulation of toll-like receptor 3 signaling pathway [BP], negative regulation of toll-like receptor 2 signaling pathway [BP], negative regulation of osteoclast proliferation [BP], negative regulation of CD40 signaling pathway [BP], positive regulation of hepatocyte proliferation [BP], negative regulation of toll-like receptor 5 signaling pathway [BP], negative regulation of toll-like receptor 4 signaling pathway [BP], B-1 B cell homeostasis [BP], negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [BP], tolerance induction to lipopolysaccharide [BP], negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [BP]
CG_imr90r1_promoter_p_RM_12_38_8			4	1.0	9.60E-05	LILRB1	negative regulation of osteoclast development [BP], HLA-A specific inhibitory MHC class I receptor activity [MF], negative regulation of CD8-positive, alpha-beta T cell activation [BP], negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [BP], negative regulation of transforming growth factor-beta secretion [BP], negative regulation of interleukin-12 secretion [BP], negative regulation of interleukin-10 secretion [BP], positive regulation of gamma-delta T cell activation involved in immune response [BP], negative regulation of interferon-beta secretion [BP]
CG_imr90r1_promoter_p_RM_18_4_1			2	1.0	1.84E-04	NUS1, AWAT1, ATL1, FMN2, SLC16A7	pyruvate secondary active transmembrane transporter activity [MF], meiotic chromosome movement towards spindle pole [BP], endoplasmic reticulum membrane [CC], long-chain-alcohol O-fatty-acyltransferase activity [MF]
CG_imr90r1_promoter_p_RM_12_81_4			3	1.0	1.46E-04	BCAM	laminin receptor activity [MF]
CG_imr90r1_promoter_p_RM_12_63_5			1	0.5	1.26E-04	SLC11A1, POU3F3	divalent metal ion export [BP], metal ion:hydrogen antiporter activity [MF], metanephric macula densa development [BP], cellular cadmium ion homeostasis [BP], nitrite transport [BP], tertiary granule membrane [CC]
CG_imr90r1_promoter_p_RM_12_19_9			5	1.0	8.38E-05	TAC1, KL, ANXA1	substance P receptor binding [MF], acute inflammatory response [BP], neutrophil clearance [BP]
CG_imr90r1_promoter_p_RM_12_48_10			3	1.0	7.05E-05	BMP1, MMP23B, GNGT1, PMPCB, TUB	phototransduction [BP], metalloendopeptidase activity [MF]
CG_imr90r1_promoter_p_RM_20_9_1			1	0.5	8.98E-05	IL10RA, SLC34A2	interleukin-10 receptor activity [MF], response to fructose stimulus [BP]
CG_imr90r1_promoter_p_RM_12_94_5			1	0.5	2.50E-04	IL33, PVRL2	negative regulation of immunoglobulin secretion [BP], virion attachment, binding of host cell surface coreceptor [BP]
CG_imr90r1_promoter_p_RM_12_93_7			3	1.0	2.38E-04	PAFAH1B1, CHRNB2, AATF, NTNG2, SPAG6	axonogenesis [BP], establishment of centrosome localization [BP], astral microtubule [CC], negative regulation of superoxide anion generation [BP], central nervous system projection neuron axonogenesis [BP], spermatid development [BP], dynein intermediate chain binding [MF], lateral geniculate nucleus development [BP], cell projection organization [BP]
CG_imr90r1_promoter_p_RM_12_101_5			2	0.5	2.64E-04	MARK1	phosphatidic acid binding [MF]
CG_imr90r1_promoter_p_RM_14_6_1			2	1.0	2.68E-04	PAFAH1B1, MGST2	leukotriene-C4 synthase activity [MF], nuclear envelope disassembly [BP], astral microtubule [CC], dynein intermediate chain binding [MF], osteoclast development [BP], establishment of centrosome localization [BP]
CG_imr90r1_promoter_p_RM_12_4_4			3	1.0	9.36E-05	KCNMB2	regulation of vasoconstriction [BP]
CG_imr90r1_promoter_p_RM_20_7_1			1	0.5	1.14E-04	HSD17B4	medium-chain fatty-acyl-CoA metabolic process [BP], 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [MF], 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [MF], very long-chain fatty-acyl-CoA metabolic process [BP], long-chain-enoyl-CoA hydratase activity [MF]
CG_imr90r1_promoter_p_RM_12_9_11			3	0.5	1.54E-04	ADCYAP1, ATN1	positive regulation of somatostatin secretion [BP], toxin receptor binding [MF], pituitary adenylate cyclase-activating polypeptide receptor binding [MF], pituitary adenylate cyclase activating polypeptide activity [MF], negative regulation of acute inflammatory response to non-antigenic stimulus [BP]
CG_imr90r1_promoter_p_RM_12_105_5			1	0.5	1.93E-04	NOG, GAR1, WDR19	snRNA pseudouridine synthesis [BP], fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], box H/ACA snoRNP complex [CC], limb development [BP], negative regulation of cytokine activity [BP], embryonic skeletal system development [BP], regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], embryonic limb morphogenesis [BP], smoothened signaling pathway involved in dorsal/ventral neural tube patterning [BP], positive regulation of glomerulus development [BP], ear morphogenesis [BP], dorsal/ventral pattern formation [BP], myotome development [BP], ciliary receptor clustering involved in smoothened signaling pathway [BP], somite development [BP]
CG_imr90r1_promoter_p_RM_14_3_3			8	1.0	5.12E-05	NSDHL, TGS1	sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [MF], RNA trimethylguanosine synthase activity [MF], 7-methylguanosine cap hypermethylation [BP]
CG_imr90r1_promoter_p_RM_12_20_2			5	1.0	2.04E-04	ISL1, THBS1, XIAP, ACSL3, OSBP2, SPACA3	negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [BP], negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [BP], secretory granule [CC], outflow tract morphogenesis [BP], positive regulation of macrophage activation [BP], negative regulation of cGMP-mediated signaling [BP], negative regulation of dendritic cell antigen processing and presentation [BP], lipid transport [BP], positive regulation of phosphatidylcholine biosynthetic process [BP], negative regulation of nitric oxide mediated signal transduction [BP], positive regulation of eukaryotic cell surface binding [BP], endocardial cushion development [BP]
CG_imr90r1_promoter_p_RM_14_1_6			8	1.0	1.05E-04	GRIK2, DAO, PLCG2	glutamate receptor signaling pathway [BP], D-alanine catabolic process [BP], D-serine catabolic process [BP], follicular B cell differentiation [BP]
CG_imr90r1_promoter_p_RM_12_91_3			1	0.5	9.46E-05	ABCF1, MRPL41, MRPS12, RPL7L1, HES1, MRPL15	N-box binding [MF], negative regulation of stomach neuroendocrine cell differentiation [BP], negative regulation of pancreatic A cell differentiation [BP], mitochondrial ribosome [CC], lateral inhibition [BP], ribosome [CC], structural constituent of ribosome [MF], translation [BP], ribonucleoprotein complex [CC], positive regulation of mitotic cell cycle, embryonic [BP]
CG_imr90r1_promoter_p_RM_12_85_13			4	1.0	1.65E-04	NSDHL	sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [MF]
CG_imr90r1_promoter_p_RM_12_103_8			2	1.0	1.85E-04	KIAA1324	positive regulation of vacuole organization [BP], positive regulation of autophagic vacuole assembly [BP]
CG_imr90r1_promoter_p_RM_12_31_4			2	0.5	1.11E-04	FOXB1	mammillary body development [BP], cell migration in diencephalon [BP], hypothalamus cell migration [BP], inferior colliculus development [BP], mammillothalamic axonal tract development [BP]
CG_imr90r1_promoter_p_RM_12_71_9			2	1.0	1.37E-04	NDUFS7, NDUFAF3	mitochondrial respiratory chain complex I assembly [BP]
CG_imr90r1_promoter_p_RM_18_2_1			1	0.5	1.36E-04	ACTN4	actin crosslink formation [BP], positive regulation of sodium:hydrogen antiporter activity [BP], positive regulation of pinocytosis [BP]
CG_imr90r1_promoter_p_RM_14_13_2			1	0.5	5.70E-04	PCDHGA4, PCDHGA11, PCDHGA12, PCDHGA5, PCDHGB3	homophilic cell adhesion [BP], calcium ion binding [MF]
CG_imr90r1_promoter_p_RM_12_135_7			1	0.5	1.45E-04	CRCP	DNA polymerase III complex [CC], calcitonin gene-related polypeptide receptor activity [MF]
CG_imr90r1_promoter_p_RM_12_107_7			2	1.0	1.26E-04	FEM1B, DAB2IP, SYK	activation of JUN kinase activity [BP], death receptor binding [MF]
CG_imr90r1_promoter_p_RM_12_33_5			3	0.5	6.42E-05	BCMO1, NDEL1	beta-carotene 15,15'-monooxygenase activity [MF], oligopeptidase activity [MF], vitamin A biosynthetic process [BP]
CG_imr90r1_promoter_p_RM_14_11_2			3	0.5	7.01E-05	USP14, LRRK2, FDFT1	external side of mitochondrial outer membrane [CC], negative regulation of neuron maturation [BP], farnesyl-diphosphate farnesyltransferase activity [MF], GTP-dependent protein kinase activity [MF], squalene synthase activity [MF], regulation of proteasomal protein catabolic process [BP], negative regulation of branching morphogenesis of a nerve [BP]
CG_imr90r1_promoter_p_RM_12_77_5			2	1.0	6.74E-05	FUT8, TIRAP, PKD2	N-glycan fucosylation [BP], positive regulation of chemokine (C-X-C motif) ligand 1 production [BP], metanephric cortex development [BP], glycoprotein 6-alpha-L-fucosyltransferase activity [MF], positive regulation of interleukin-15 production [BP], TIRAP-dependent toll-like receptor 4 signaling pathway [BP], positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [BP], renal artery morphogenesis [BP], metanephric cortical collecting duct development [BP], Toll-like receptor 2 binding [MF]